Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei
- 1 December 1988
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 18 (12), 1951-1957
- https://doi.org/10.1002/eji.1830181213
Abstract
The present findings establish the lack of genetic restriction of the humoral immune response to sporozoites of Plasmodium berghei, corraborating earlier observations that mice of different strains can be protected by immunization with irradiated sporozoites. Most, if not all, anti-sporozoite antibodies are directed against the repetitive B cell epitope of the circumsporozoite (CS) protein. However, neither a peptide containing a dimer of this repeat (17.1), nor a peptide polymer containing multiple repeats induced an antibody response in mice of different H-2 and different genetic backgrounds. A yeast-derived recombinant, containing the repeat domain and part of the surrounding amino and carboxy-terminal regions of the P. berghei CS protein, induces very different levels of antibody in mice of diverse H-2 haplotypes. H-2j mice are high responders and the immunized mice are extensively protected against sporozoite challenge. The lymph node cells of the H-2j mice (but not from other strains) proliferated in the presence of peptide N, contained in the amino terminal region of the CS recombinant. Additional H-%-restricted T cell epitopes have been identified in amino and carboxy-terminal regions of the CS protein, and mice of most of the strains recognized multiple T cell epitopes. Two peptides representing T cell epitopes were synthesized in tandem with a peptide representing the B cell epitope, and were assayed for T helper activity in vivo. The antibody response of mice, primed by a single injection of sporozoites, was boosted very effectively by the administration of peptide N+17.1 or peptide B-4 +17.1. The B-4 T cell epitope is located in the carboxy-terminal region of the CS protein and is recognized by mice of at least four different H-2 haplotypes. These observations demonstrate that the immune response to the CS protein of P. berghei is not genetically restricted and that it contains several T cell epitopes, some of which can function as helper epitopes. In addition, they show that a synthetic sporozoite vaccine can boost the immune response to sporozoites.This publication has 21 references indexed in Scilit:
- Epitopes recognized by human t lymphocytes on malaria circumsporozoite proteinEuropean Journal of Immunology, 1988
- Synthetic peptide vaccine confers protection against murine malaria.The Journal of Experimental Medicine, 1987
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine.The Journal of Experimental Medicine, 1987
- Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite ProteinScience, 1987
- Mechanisms for the removal of benzyl protecting groups in synthetic peptides by trifluoromethanesulfonic acid-trifluoroacetic acid-dimethyl sulfideJournal of the American Chemical Society, 1986
- Effect of carrier on the immunogenic capacity of synthetic cholera vaccineMolecular Immunology, 1985
- Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.The Journal of Experimental Medicine, 1982
- Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responsesThe Journal of Experimental Medicine, 1982
- Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.The Journal of Experimental Medicine, 1980